Rockwell Medical Inc

NASDAQ:RMTI   3:39:56 PM EDT
1.52
+0.04 (+2.37%)
Products

Rockwell Medical Submits Supplemental Data To FDA For IND Application For Phase 2 FPC Home Infusion Trial

Published: 05/12/2022 12:18 GMT
Rockwell Medical Inc (RMTI) - Rockwell Medical Submits Supplemental Data to FDA for Ind Application for Phase 2 Fpc Home Infusion Trial.
Rockwell Medical - Additional Data Relate to Physical, Chemical, Microbiological Stability of Fpc in Support of Suggested Method of Administration.
Rockwell Medical - If FDA Has No Further Questions/requirements Related to Submission, Would Expect Trial to Start Shortly After Review Period Ends.